Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
Quick Stats
Mar 30, 202647.8
AI Score
HOLD10.26
Volume Ratio
May 05, 2026
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
VRDN Stock Summary
Last updated Mar 30, 2026
VRDN is currently trading at $18.53, positioned below its 200-day moving average of $24.4, suggesting bearish momentum. The stock has a 52-week range of $9.9 to $34.29.
Technical Analysis: The 50-day moving average stands at $29.53, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 19.53, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.02, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates VRDN at 47.8/100 with a HOLD recommendation.
VRDN (Viridian Therapeutics, Inc. Common Stock) Indicators
Last updated Mar 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 19.53 |
| CMF (20) | 0.02 |
| ROC (10) | -35.593 |
| ADX (14) | 15.654 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -1.258 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -87.893 |
| MFI (14) | 18.429 |
VRDN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
VRDN Price vs Max Options Open Interest
VRDN Max Change In Options Open Interest
VRDN Options - Sort by Max open Interest (near term)
31st March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRDN Daily Out of Money Options - Sort by Max open Interest (near term)
31st March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRDN Daily In the Money Options - Sort by Max open Interest (near term)
31st March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
VRDN Most Active Options by Volume(near term)
31st March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Viridian Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
VRDN Moving Averages Analysis
VRDN (Viridian Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Mar 30, 2026
| Days | MA |
|---|---|
| 10 | 26.84 |
| 20 | 27.93 |
| 30 | 28.21 |
| 50 | 29.53 |
| 100 | 30.12 |
| 200 | 24.4 |
VRDN Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.8 billion |
| Earnings/Share ($) | -3.32 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.792 |
| EPS Estimate Next Year ($) | -2.0487 |
| WallStreet Target Price ($) | 41.7647 |
| Most Recent Quarter |